Literature DB >> 19336592

Influence of comorbid conditions on asthma.

L-P Boulet1.   

Abstract

Various conditions such as rhinosinusitis, gastro-oesophageal reflux disease, psychological disturbances, chronic infections and obstructive sleep apnoea are often observed in asthmatic patients and may affect asthma control and outcomes. These comorbidities may change the asthma phenotype, be part of the same pathophysiological process, act as confounding factors in the diagnosis or assessment of control of asthma, and/or result from specific environmental exposures. The influences of these conditions on asthma are variable and for many of them still uncertain; nevertheless, they may alter asthma responses to current therapy. A systematic evaluation and an appropriate treatment of asthma-associated comorbid conditions should be part of asthma management, particularly for severe disease. With regard to clinical research, associated conditions may influence the results of trials and should be taken into account in the subjects' inclusion criteria and analysis of data.

Entities:  

Mesh:

Year:  2009        PMID: 19336592     DOI: 10.1183/09031936.00121308

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  69 in total

1.  [Treatment strategies for asthma].

Authors:  S Korn; C Taube; R Buhl
Journal:  Internist (Berl)       Date:  2012-04       Impact factor: 0.743

Review 2.  Asthma and Medicines - Long-Term Side-Effects, Monitoring and Dose Titration.

Authors:  Satnam Kaur; Varinder Singh
Journal:  Indian J Pediatr       Date:  2018-01-06       Impact factor: 1.967

3.  Utilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010.

Authors:  Shih-Feng Chiu; Christina M L Kelton; Jeff Jianfei Guo; Patricia R Wigle; Alex C Lin; Sheryl L Szeinbach
Journal:  Am Health Drug Benefits       Date:  2011-05

4.  Validity and Reliability of the Assessment Tool for Asthma (ATA) Questionnaire: the ATA Study.

Authors:  Bilun Gemicioğlu; Dilşad Mungan; Sevim Bavbek; Füsun Yıldız; Mehmet Polatlı; Sibel Naycı; Ferda Öner Erkekol; Hatice Türker; Hakan Günen; Güngor Çamsarı; Öznur Abadoğlu; Arif Çımrın; A Berna Dursun; Özlem Göksel; Seçil Kepil Özdemir; Şermin Börekci; Ömür Aydın; Birsen Ocaklı; Aygün Gür; Arzu Baygul; Zeynep Mısırlıgil
Journal:  Turk Thorac J       Date:  2020-03-01

5.  Multimorbidity medications and poor asthma prognosis.

Authors:  Sébastien Chanoine; Margaux Sanchez; Isabelle Pin; Sofia Temam; Nicole Le Moual; Agnès Fournier; Christophe Pison; Jean Bousquet; Pierrick Bedouch; Marie-Christine Boutron-Ruault; Raphaëlle Varraso; Valérie Siroux
Journal:  Eur Respir J       Date:  2018-04-12       Impact factor: 16.671

Review 6.  Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients.

Authors:  Hoang Kim Tu Trinh; Ga-Young Ban; Ji-Ho Lee; Hae-Sim Park
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

7.  Major depressive disorder is associated with subsequent adult-onset asthma: a population-based cohort study.

Authors:  T-C Shen; C-L Lin; C H Liao; C-C Wei; F-C Sung; C-H Kao
Journal:  Epidemiol Psychiatr Sci       Date:  2016-09-19       Impact factor: 6.892

8.  Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults.

Authors:  M D Lougheed; C Lemière; S D Dell; F M Ducharme; J Mark Fitzgerald; R Leigh; C Licskai; B H Rowe; D Bowie; A Becker; Louis-Philippe Boulet
Journal:  Can Respir J       Date:  2010 Jan-Feb       Impact factor: 2.409

9.  Coexisting chronic conditions associated with mortality and morbidity in adult patients with asthma.

Authors:  Kaharu Sumino; Katiuscia O'Brian; Brian Bartle; David H Au; Mario Castro; Todd A Lee
Journal:  J Asthma       Date:  2014-01-27       Impact factor: 2.515

Review 10.  Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.

Authors:  Vanessa M McDonald; Isabel Higgins; Peter G Gibson
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.